Your browser doesn't support javascript.
loading
Adult medulloblastoma in an Australian population.
Parakh, Sagun; Davies, Amy; Westcott, Kerryn; Roos, Daniel; Abou-Hamden, Amal; Ahern, Elizabeth; Lau, Peter K H; Cheruvu, Sowmya; Pranavan, Ganesalingam; Pullar, Andrew; Lynam, James; Gzell, Cecelia; Whittle, James R; Cain, Sarah; Inglis, Po-Ling; Harrup, Rosemary; Anazodo, Antoinette; Hovey, Elizabeth; Cher, Lawrence; Gan, Hui K.
Affiliation
  • Parakh S; Olivia Newton John Cancer Research Institute, Melbourne, Australia; Austin Health, Melbourne, Australia; La Trobe University, School of Cancer Medicine, Heidelberg, Victoria, Australia. Electronic address: Sagun.parakh@onjcri.org.au.
  • Davies A; Monash Health, Melbourne, Australia.
  • Westcott K; Olivia Newton John Cancer Research Institute, Melbourne, Australia.
  • Roos D; Royal Adelaide Hospital, Adelaide, Australia; University of Adelaide, Adelaide, Australia.
  • Abou-Hamden A; Royal Adelaide Hospital, Adelaide, Australia; University of Adelaide, Adelaide, Australia.
  • Ahern E; Monash Health, Melbourne, Australia; Monash University, Melbourne, Australia.
  • Lau PKH; Sir Charles Gairdner Hospital, Perth, Australia.
  • Cheruvu S; Sir Charles Gairdner Hospital, Perth, Australia.
  • Pranavan G; The Canberra Hospital, Canberra, Australia; The Australian National University, Canberra, Australia.
  • Pullar A; Princess Alexandra Hospital, Brisbane, Australia.
  • Lynam J; Calvary Mater Newcastle, Newcastle, Australia; University of Newcastle, Newcastle, Australia.
  • Gzell C; GenesisCare, Sydney, Australia.
  • Whittle JR; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, Australia; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
  • Cain S; Royal Melbourne Hospital, Melbourne, Australia.
  • Inglis PL; Royal Brisbane and Women's Hospital, Brisbane, Australia.
  • Harrup R; Royal Hobart Hospital, Hobart, Australia.
  • Anazodo A; Department of Medical Oncology, Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Sydney, Australia.
  • Hovey E; Department of Medical Oncology, Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Sydney, Australia; Faculty of Medicine, The University of New South Wales.
  • Cher L; Austin Health, Melbourne, Australia.
  • Gan HK; Olivia Newton John Cancer Research Institute, Melbourne, Australia; Austin Health, Melbourne, Australia; La Trobe University, School of Cancer Medicine, Heidelberg, Victoria, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, Australia.
J Clin Neurosci ; 102: 65-70, 2022 Aug.
Article in En | MEDLINE | ID: mdl-35728397
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cerebellar Neoplasms / Medulloblastoma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Child / Humans Country/Region as subject: Oceania Language: En Journal: J Clin Neurosci Journal subject: NEUROLOGIA Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cerebellar Neoplasms / Medulloblastoma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Child / Humans Country/Region as subject: Oceania Language: En Journal: J Clin Neurosci Journal subject: NEUROLOGIA Year: 2022 Document type: Article